- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Viewing devices make mammography easier on the eyes
Two 5-megapixel liquid crystal monitors were released today at the RSNA meeting. The Lumimed monitors, shown by Broadwest as prototypes at the 2004 meeting, can be set to display images of individual breasts, as well as mediolateral and craniocaudal views. The monitors are ready for production, pending approval by the FDA.
Two 5-megapixel liquid crystal monitors were released today at the RSNA meeting. The Lumimed monitors, shown by Broadwest as prototypes at the 2004 meeting, can be set to display images of individual breasts, as well as mediolateral and craniocaudal views. The monitors are ready for production, pending approval by the FDA.
The two new devices have higher luminance than standard mammography viewing stations and a maximized viewing surface area, according to Jack Donovan, president of Broadwest.
Additionally, an ergonomic table for positioning the monitors will be available commercially in the first quarter of 2006. The table can be lowered, raised, and tilted so radiologists can adjust viewing whether they are in a seated or standing position. The table also incorporates features intended to reduce cabling tangles.
"The table has many accessories to minimize cabling and make mammography viewing comfortable for radiologists," Donovan said.
The 5-megapixel monitor pair and the ergonomic table will be sold separately.
Can Portable Dual-Energy X-Ray be a Viable Alternative to CT in the ICU?
September 13th 2024The use of a portable dual-energy X-ray detector in the ICU at one community hospital reportedly facilitated a 37.5 percent decrease in chest CT exams in comparison to the previous three months, according to research presented at the American Society of Emergency Radiology (ASER) meeting in Washington, D.C.
New Meta-Analysis Examines MRI Assessment for Treatment of Esophageal Cancer
September 12th 2024Diffusion-weighted MRI provided pooled sensitivity and specificity rates of 82 percent and 81 percent respectively for gauging patient response to concurrent chemoradiotherapy for esophageal cancer, according to new meta-analysis.
Study for Emerging PET/CT Agent Reveals ‘New Standard’ for Detecting Clear Cell Renal Cell Carcinoma
September 11th 2024Results from a multicenter phase 3 trial showed that the PET/CT imaging agent (89Zr)Zr-girentuximab had an 85.5 percent mean sensitivity rate for the diagnosis of clear cell renal cell carcinoma.
Can Radiomics and Autoencoders Enhance Real-Time Ultrasound Detection of Breast Cancer?
September 10th 2024Developed with breast ultrasound data from nearly 1,200 women, a model with mixed radiomic and autoencoder features had a 90 percent AUC for diagnosing breast cancer, according to new research.
